Taking people in EgyptPhase 3
Impact of P53 and SIRT1 in Type 2 Diabetes
Key facts
- Where
- Cairo, EgyptSee the site
- Phase
- Phase 3
Where in Egypt
- Sherief Abd-ElsalamCairo, EgyptTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sherief Abd-Elsalam
- Trial code
- NCT03925714
- Record updated
- 24 April 2019
- Original description
Investigating the impact of p53 and SIRT1 in the development of type 2 DMRead full original descriptionShow less
Investigating the Impact of p53 and SIRT1 in the Development of Type 2 DM Through the Treatment of Prediabetic Individuals by Either Nigetella Salivata or Metformin
Investigating the impact of p53 and SIRT1 in the development of type 2 DM
Inclusion: Prediabetic subjects.
Exclusion: Confirmed diabetes; Hepatic or renal impairment.